Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s ...
The resolution could potentially restrict how telehealth programs offer cheaper versions known as compounded drugs ...
Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results